Kuriakose Emil

Kuriakose Emil is listed in filings as Chief Medical Officer at Terns Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 5, 2026, including sale activity. Recent filings connect the profile to Terns Pharmaceuticals, Inc. (TERN). The current snapshot covers public activity from Dec 16, 2024 to May 5, 2026. Reported amounts are shown as $4.3M to $3.6M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.